Rodolfo Chicas-Sett

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 28, 2026
Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

|Jan 25, 2025
Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study.

Barbara Salas-Salas, Laura Ferrera-Alayon, Alberto Espinosa-Lopez

|Apr 27, 2024
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.

Juan Zafra, Juan Luis Onieva, Javier Oliver

|Aug 09, 2020
Immunoradiotherapy as An Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent.

Rodolfo Chicas-Sett, Juan Zafra-Martin, Ignacio Morales-Orue

|Jun 01, 2019
A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?

R Chicas Sett, O Pons Llanas, F Celada Álvarez

|May 05, 2019
Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.

Rodolfo Chicas-Sett, Ignacio Morales-Orue, Juan Castilla-Martinez

Pageof 1

Frequent Collaborators

3 joint publications

Juan Zafra-Martin

2 joint publications

Juan Luis Onieva

1 joint publications

Ignacio Morales-Orue

1 joint publications

Javier Oliver